Peter Hentschel - Chairman

Peter Hentschel comes from a position as Senior Vice President of Mölnlycke Health Care’s Wound Care and Surgical divisions where he worked during 1998-2006 and where he had the responsibility of up to 2500 employees worldwide. Prior to that he worked with SCA Hygiene Products where he was the Vice President of Baby Diapers - and the Incontinence Business. Peter has experience from being a board member and chairman of eight companies.

Peter Hentschel has deep and varied skills in the Health Care and Consumer markets and he has extensive experience from working internationally. He has worked both with restructuring of existing businesses and the building of new ones and he has been deeply involved in two exit processes.

Peter has a MSc in Chemical Engineering from Chalmers University of Technology and he has studied Business administration at Gothenburg University.

 

Ingvar Andersson

Ingvar is the CEO of Chalmersinvest since 1998, and he has more than 20 years experience of developing and investing in young companies as well as other forms of commercialization of research results. Ingvar has six years of experience in managerial positions in large multinational companies, in R&D, design, business and product development. He is a board member in LC-Tec Holding (public), Kartena (public), Parans Solar Lighting, Oxeon and Nanoxis. He is also chairman of several companies within the Chalmers group.

Ingvar is a member of the Royal Academy of Engineering Sciences and he has a PhD in mechanical engineering from Chalmers University of Technology.

 

Birgit Fibian

Birgit Fibian has more than 15 years of experience in sales and marketing in the medical device industry. She has expert knowledge in portfolio management, product positioning and branding, life cycle management and launch to market, project management and application to market research.
She has worked with sales to hospitals, direct sales to patients, international dealer networks and home care operations. She has been the European Marketing Manager for Patient Interfaces of ResMed in Basel, Switzerland, where she managed a product sector of $50 million per annum.

Birgit Fibian has an MBA from City University in Seattle, USA.

Julian Nicholas

Julian Nicholas has since 1999 worked on various management positions at Smith & Nephew and he is currently the Director of Intellectual Property and Licensing at Smith & Nephew’s Biologics and Spine Global Business unit.

He was the Managing Director of a  plant biotech start-up that was sold to Sandoz, at the time the world’s largest seed company.

During his career, Julian has managed refinancing, acquisitions and disposals and has completed countless research and development collaborations. He has also analyzed what makes successful business alliances and incorporated that learning into contract construction and management to assist value creation.

Julian has a Ph.D. from Plant Science at the University of Nottingham and an MBA from Theseus Institue in France.